Repligen Stock Quote
$90.30 $1.88 2.1%
BATS BZX Real Time Price as of December 6, 2019, 4:00 p.m. EST View Interactive RGEN Charts

A biopharmaceutical company focused on the development of novel therapeutics for the treatment of diseases of the central nervous system.

News & Analysis: Repligen

The Fool has written over 100 articles on Repligen.


Market Moves


3 Things Repligen Investors Need to Watch

The year may be drawing to a close, but this biomanufacturing stock -- and any investor interested in it -- has plenty to look forward to.

3 Stocks to Buy and Hold for Decades

These businesses offer the potential for above-average returns that could receive a huge helping hand from the power of compound interest.

Repligen Grows Revenue 48% in Q2

The bioprocess leader keeps growing at an incredible pace thanks to acquisitions and surging customer demand.

Interactive Chart